Search Results - Pascal Benkert
- Showing 1 - 8 results of 8
-
1
Combining randomized and non‐randomized data to predict heterogeneous effects of competing treatments Autoría: Konstantina Chalkou, Tasnim Hamza, Pascal Benkert, Jens Kuhle, Chiara Zecca, Gabrielle Simoneau, Fabio Pellegrini, Andrea Manca, Matthias Egger, Georgia Salanti
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis Polyneuropathy Autoría: Valentin Loser, Pascal Benkert, Alex Vicino, Nicolas Ghika, Pansy Lim Dubois Ferrière, Chantal Daigneault, Thierry Kuntzer, Aleksandra Maleska Maceski, Jens Kuhle, Marie Théaudin
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms Autoría: Sonja M. Kagerer, Swapnil Awasthi, Stephan Ripke, Aleksandra Maceski, Pascal Benkert, Aïda B. Fall, Peter Riederer, Peter Fischer, Susanne Walitza, Edna Grünblatt, Jens Kuhle, Paul G. Unschuld
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
4
Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis Autoría: Alessandro Cagol, Pascal Benkert, Sabine Schaedelin, Mario Ocampo‐Pineda, Noemi Montobbio, Po‐Jui Lu, Batuhan Ayci, Antonia Wenger, Alfi Aran Shukur, Kornelius Kaim, Lester Melie‐Garcia, Matthias Weigel, Alessio Signori, Pasquale Calabrese, Ludwig Kappos, Maria Pia Sormani, Jens Kuhle, Cristina Granziera
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
5
Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis Autoría: Nahid Moradi, Sifat Sharmin, Charles B. Malpas, Jens Kuhle, Pascal Benkert, David Leppert, Eva Kubala Havrdová, Dana Horáková, Pavlína Kleinová, Tomas Uher, Ali Manouchehrinia, Jan Hillert, Tomas Olsson, Ingrid Kochum, Bruce V. Taylor, Michael Barnett, Trevor J. Kilpatrick, Katherine Buzzard, Tomas Kalincik
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
6
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis Autoría: Nicolás Fissolo, Pascal Benkert, Andreu Vilaseca‐Jolonch, Yolanda Blanco, Harald Hegen, Klaus Berek, Francisco Pérez‐Miralles, Konrad Rejdak, Luisa Villar, Enric Monreal, Roberto Alvarez‐Lafuente, Franziska Bachhuber, Hayrettin Tumani, Sergio Martínez‐Yelamos, Antonio Sánchez‐López, Antonio García‐Merino, Lucía Gutiérrez, Tamara Castillo‐Triviño, Jan Lycke, Igal Rosenstein, Nieves Téllez, Roberto Furlan, Jan D. Lünemann, Michael Khalil, Jens Kuhle, Xavier Montalban, Manuel Comabella
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
7
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age‐ and BMI ‐Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response... Autoría: Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, Johanna Oechtering, Sabine Schaedelin, Lisa Hofer, Amar Zadic, Juan Francisco Vilchez Gomez, Lester Melie‐Garcia, Alessandro Cagol, Riccardo Galbusera, Sebastian Finkener, Patrice Lalive, Marjolaine Uginet, Stefanie Müller, Caroline Pot, Amandine Mathias, Renaud Du Pasquier, Robert Hoepner, Andrew Chan, Giulio Disanto, Chiara Zecca, Marcus D’Souza, Lars G. Hemkens, Tobias Derfuss, Özgür Yaldizli, Patrick Roth, Claudio Gobbi, David Brassat, Björn Tackenberg, Henrik Zetterberg, Tjalf Ziemssen, Heinz Wiendl, Klaus Berger, Marco Hermesdorf, Fredrik Piehl, Ludwig Kappos, Cristina Granziera, Ahmed Abdelhak, David Leppert, Eline A. J. Willemse, Pascal Benkert, Jens Kuhle
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
8
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosi... Autoría: Pascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin, Johanna Oechtering, Amar Zadic, Juan Francisco Vilchez Gomez, Lester Melie‐Garcia, Alessandro Cagol, Riccardo Galbusera, Suvitha Subramaniam, Johannes Lorscheider, Edoardo Galli, Jannis Mueller, Bettina Fischer‐Barnicol, Lutz Achtnichts, Oliver Findling, Patrice H. Lalive, Claire Bridel, Marjolaine Uginet, Stefanie Müller, Caroline Pot, Amandine Mathias, Renaud Du Pasquier, Anke Salmen, Robert Hoepner, Andrew Chan, Giulio Disanto, Chiara Zecca, Marcus D'Souza, Lars G. Hemkens, Özgür Yaldizli, Tobias Derfuss, Patrick Roth, Claudio Gobbi, David Brassat, Björn Tackenberg, Rosetta Pedotti, Catarina Raposo, Jorge Oksenberg, Heinz Wiendl, Klaus Berger, Marco Hermesdorf, Fredrik Piehl, David Conen, Andreas Buser, Ludwig Kappos, Michael Khalil, Cristina Granziera, Ahmed Abdelhak, David Leppert, Eline A.J. Willemse, Jens Kuhle
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso